Notice Number: NOT-NR-17-023
Key Dates
Release Date: May 10, 2017
Issued by
National Institute of Nursing Research (NINR)
Purpose
The purpose of this Notice is to inform potential applicants that the National Institute of Nursing Research (NINR) is participating in PA-17-181, " Innovations in HIV Testing, Adherence, and Retention to Optimize HIV Care Continuum Outcomes (R01)"
The following additions have been made to reflect NINR's participation in this FOA:
Components of Participating Organizations
National Institute of Nursing Research (NINR)
Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.361
National Institute of Nursing Research (NINR)
NINR’s participation in this FOA is limited to HIV/AIDS-related research that addresses the Office of AIDS Research Priority to “improve prevention or treatment of HIV-associated comorbidities and co-infections.” Please contact the NINR program officer noted on the FOA for questions about this announcement.
The following contact person has been added:
Scientific/Research Contact(s)
Rebecca Henry, PhD, BSN, RN
National Institute of Nursing Research (NINR)
Telephone: 301-594-5976
Email: Rebecca.Henry@nih.gov
Financial/Grants Management Contact(s)
Oster, Kelli
National Institute of Nursing Research (NINR)
Telephone: 301-594-2177
Email: osterk@mail.nih.gov
All other aspects of this FOA remain unchanged.
Inquiries
Please direct all inquiries to:
Rebecca Henry, PhD, BSN, RN
National Institute of Nursing Research (NINR)
Telephone: 301-594-5976
Email: Rebecca.Henry@nih.gov